California Public Employees Retirement System Purchases 997 Shares of Mettler-Toledo International, Inc. $MTD

California Public Employees Retirement System lifted its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 2.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 35,279 shares of the medical instruments supplier’s stock after buying an additional 997 shares during the period. California Public Employees Retirement System owned approximately 0.17% of Mettler-Toledo International worth $41,443,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Bank of New York Mellon Corp grew its holdings in Mettler-Toledo International by 71.3% in the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after purchasing an additional 376,419 shares during the last quarter. Norges Bank acquired a new stake in shares of Mettler-Toledo International in the 2nd quarter worth $360,126,000. Alliancebernstein L.P. increased its position in Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after buying an additional 126,147 shares in the last quarter. PineStone Asset Management Inc. increased its position in Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock valued at $392,766,000 after buying an additional 98,737 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Mettler-Toledo International by 42.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier’s stock valued at $361,030,000 after buying an additional 90,395 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insider Buying and Selling at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 1,000 shares of the firm’s stock in a transaction on Tuesday, November 25th. The shares were sold at an average price of $1,511.00, for a total transaction of $1,511,000.00. Following the sale, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,990,168. This trade represents a 15.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Patrick Kaltenbach sold 2,000 shares of Mettler-Toledo International stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $1,462.50, for a total transaction of $2,925,000.00. Following the completion of the transaction, the chief executive officer directly owned 3,670 shares of the company’s stock, valued at $5,367,375. The trade was a 35.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 19,565 shares of company stock worth $28,683,737. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Stock Performance

Shares of MTD opened at $1,404.68 on Thursday. The business’s 50-day moving average is $1,398.11 and its two-hundred day moving average is $1,289.21. The company has a market capitalization of $28.70 billion, a P/E ratio of 35.03, a P/E/G ratio of 4.43 and a beta of 1.40. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. The firm had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $997.36 million. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on MTD shares. Morgan Stanley began coverage on shares of Mettler-Toledo International in a report on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 price objective on the stock. Stifel Nicolaus upped their price target on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Wells Fargo & Company lifted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. Barclays boosted their price objective on shares of Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a report on Monday, November 10th. Finally, Bank of America raised their target price on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research note on Monday, September 22nd. Five research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $1,424.17.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.